Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to test an optimized control system for sensor-guided
(physician administered) delivery of glucagon, and test Proof-of-Concept (POC) in a clinical
setting in patients with severe hypoglycemia following bariatric surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Xeris Pharmaceuticals
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)